NanoString CosMx Spatial Gene Expression Library Preparation Kits (6K)
Closed Pre-Solicitation Posted
A newer solicitation was posted. See the latest solicitation from .
- Solicitation number
- 75N91024Q00139
- Agency
- National Cancer Institute National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
-
- John Russell john.russell3@nih.gov (240) 276-6892
Notice details come from SAM.gov. Updated .
About this opportunity
This Sources Sought Notice is issued by the National Cancer Institute (NCI), part of the National Institutes of Health and Department of Health and Human Services, to identify qualified businesses, particularly small businesses, that are interested in and capable of providing NanoString CosMx Spatial Gene Expression Library Preparation Kits (6K). The purpose is to assist the NCI in determining the appropriate acquisition method, including whether a small business set-aside is possible. The required items include RNA extraction and imaging kits, as well as the CosMx SMI flow cell and imaging trays. Responses are due by 10:00 AM EST on June 28, 2024 and should provide details on the company's profile, relevant past performance, product/service capabilities, and pricing. The NCI will use the information provided to potentially issue a solicitation in the future, but responses to this notice will not be considered an adequate response to any subsequent solicitation.
This procurement has no set-aside designation. The NCI has not identified any potential incumbents or current contractors. The budget range or award value is not specified. The required quantity is 6K of the NanoString CosMx Spatial Gene Expression Library Preparation Kits, with a delivery timeline of 30 calendar days from the purchase order award.
Notice text
This is a Sources Sought Notice (SSN) and is for information and planning purposes only. This notice shall not be construed as a solicitation or as an obligation on the part of the National Cancer Institute (NCI). The purpose of this SSN is to identify qualified business concerns, especially small businesses, that are interested in and capable of performing the work described herein. The NCI does not intend to award a contract based on responses received nor otherwise pay for the preparation of any information submitted. Responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a small business set aside is possible. The requirement’s suggested North American Industry Classification System (NAICS) code is 325413 (In Vitro Diagnostic Substance Manufacturing) with a size standard of 1,250 employees.
THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claims against NCI shall arise because of a response to this SSN or the NCI’s use of such information furnished in response to this notice.
RESPONSE INSTRUCTIONS:
Responses to this notice shall be submitted via email to Contracting Officer, John Russell, at John.Russell3@nih.gov no later than 10:00 A.M. / P.M. EST on Friday, June 28, 2024 (06/28/24). All information furnished must be in writing and must contain enough detail to allow the NCI to determine the respondents’ ability to meet the requirements described herein. A response should not exceed 10 single-sided pages including all attachments, charts, etc. (single space, 12-point font minimum) that clearly responds to the below questions. All proprietary information should be clearly marked as such. Please reference the notice number 75N91024Q00139 on all correspondence.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s capability. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Information provided by small businesses will be given precedence over other than small business respondents in order to determine whether the requirement can be conducted as a small business set aside. After a review of the responses received, a synopsis and solicitation may be published. However, responses to this notice will not be considered an adequate response to a solicitation(s).
Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
***PLEASE SEE ATTCHED DOCUMENTS FOR MORE INFORMATION***
Attachments
| File | Type | Posted |
|---|---|---|
| SSN_75N91024Q00139.pdf | ||
| SON _NanoString (Draft).pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Brand Name - NanoString CosMx Spatial Gene Expression Library Preparation Kits (6K) | Solicitation | |
| NanoString CosMx Spatial Gene Expression Library Preparation Kits (6K) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity